Amlx stock forecast as of this week

As of this week, AMLX stock forecast reflects renewed investor interest following positive data from its lead ALS treatment trial. The stock’s short-term target range sits between $20 and $22, supported by higher-than-average trading volume in the healthcare segment. Most readers would already be aware that Amylyx Pharmaceuticals' (NASDAQ:AMLX) stock increased significantly by 34% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its financial indicators more closely to see if they had a hand to play in the recent price move. Particularly, we will be paying attention to Amylyx Pharmaceuticals' ROE today. 5 Hot Stocks to Buy Now: October's Top Picks With Major Upside Sentiment analysis on AMLX stock forecast data shows an uptick in bullish mentions across financial media and social platforms in recent weeks.